Verified
ARHGDIB
Reaktivität: Human
WB, ELISA
Wirt: Ziege
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
50 % glycerol
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Koh, Kim, Lee, Kim, Kim: "RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer." in: Clinical & experimental metastasis, Vol. 31, Issue 7, pp. 805-15, (2014) (PubMed).
Zhao, Chang, Li, Shedden, Thomas, Misek, Manoharan, Giordano, Beer, Lubman: "Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping." in: Molecular & cellular proteomics : MCP, Vol. 6, Issue 6, pp. 987-99, (2007) (PubMed).
Target
ARHGDIB
(rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))